BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.
Not yet recruiting · NCT07474961 · Registry updated 2026-03-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Waldenstrom macroglobulinemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 4 | 2026-03-16 | NCT07474961 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anne Louise Tølbøll Sørensen | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Aalborg University Hospital | Aalborg | Denmark | 54 |
| Aarhus University Hospital | Aarhus | Denmark | 95 |
| Copenhagen University Hospital - Rigshospitalet | Copenhagen | Denmark | 1 |
| Odense University Hospital | Odense | Denmark | 97 |
| Roskilde University Hospital | Roskilde | Denmark | 2 |